Tag | Content |
---|
EnhancerAtlas ID | HS131-05460 |
Organism | Homo sapiens |
Tissue/cell | ME-1 |
Coordinate | chr2:136996100-136996920 |
Target genes | |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
SPI1 | MA0080.4 | chr2:136996513-136996527 | CACTTCCTGTTTTT | - | 6.36 | ZNF263 | MA0528.1 | chr2:136996150-136996171 | GGAGGAGGTGGGGTGGGGGAG | + | 6.32 |
|
| Number of super-enhancer constituents: 7 | ID | Coordinate | Tissue/cell |
SE_09631 | chr2:136994962-136998523 | CD14 | SE_10274 | chr2:136994079-136998605 | CD19_Primary | SE_11065 | chr2:136993029-137000475 | CD20 | SE_35084 | chr2:136991573-136998521 | HeLa | SE_39801 | chr2:136995254-136997355 | Jurkat | SE_61425 | chr2:136945577-137039880 | Toledo | SE_62403 | chr2:136962507-137014815 | Tonsil |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH02I136235 | chr2 | 136993037 | 136998458 |
|
Enhancer Sequence | AGGAATCATT GCCAGAAACA CTAGAGGGCC ACTACTCTTA CGATGGGCAA GGAGGAGGTG 60 GGGTGGGGGA GGGCCAGAGA TTTTCTTTCA GGAGCTAAAT CCCAGGGCTT AGTAATGGTA 120 TTTGGCCTTA AGCCTGCAAA TGGCACTTTC ATCCAGCAAT ATAAGCCCTG AAGTTTTTCT 180 CAGCTGCAGA GAAGAGGTTT CCAGGAGGGT GTCAGTTTGG CCCTTGCTGG TGGCCTGGCC 240 TCTGCTAAAC ATCTCGGCCG TGCTCCTCCA TTTTCTGGCC GTGATAAGGC ACCCCGCCAA 300 GCATATCTCA GACAAATATC TGTATTGTTT GTGGTGTGAT TGTGACTTCC TGTCTTCCAA 360 TTTAGTTTTC TGCCTTACTT TTCACTGTCT GGGTCATTTG ATACTACATC TGGCACTTCC 420 TGTTTTTTAA GACTCTGACT CTAGTCATCT GACTGTAGAA AACAGAGGTC AACTTCTTCA 480 TAAGTGATGC CAGCTTTAGT CACTTGTTTT GGTATACTAG TTGAGATTTG CGTAAGGAAA 540 ATTGTCAGGT GTCTGCTGGT TTTCTTAGCC TCAGACACTT CCCTATTTAT AAGTTTTTGT 600 TTTTCAGACA TTGGGACTTT CTCCCCCTTG TGTGGATGTG GTGGGAGTGG GTGATCTCTG 660 CCCTGTCCCT ACAAATAATT CAACGGTGGT TCTCTCTCTC TTAAGGAGAA CTACCAGTCC 720 CGTAGATGCA GCTCTAGAAT GAGGGTGCTT TGGGCATAAC AGGCTCAGCC ATCCTTCTGG 780 TGTCTCGCCC TGTCTCCTTT CCCATCCTTG GGTTCACTTC 820
|